CD39 expression was greater in CLL patients who had not received chemotherapy than in those who had (99% versus 89%), but the difference was not statistically significant (p = 0.1), perhaps because of a wider variation in CD39 expression in CLL cells as opposed to normal B-lymphocytes. Here, ENTPD1 is linked to B-cell chronic lymphocytic leukemia.